BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 74.97%
This Quarter Est. Return
1 Year Est. Return
+74.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$274M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$34.1M
2
+$31.1M
3
+$21M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$20.1M
5
EBS icon
Emergent Biosolutions
EBS
+$18.5M

Top Sells

1
+$29.1M
2
+$23.4M
3
+$22.5M
4
NVDQ
Novadaq Technologies Inc.
NVDQ
+$16.6M
5
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$14.9M

Sector Composition

1 Healthcare 79.95%
2 Technology 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$70.6M 6.84%
5,267,911
+1,500,000
2
$65.1M 6.31%
4,305,469
+48,000
3
$46.3M 4.48%
797,704
-388,489
4
$45.6M 4.42%
1,805,352
+731,304
5
$40.8M 3.96%
2,592,649
+95,600
6
$34.1M 3.31%
+1,609,696
7
$31.1M 3.01%
+2,233,173
8
$29.3M 2.84%
3,472,054
+1,250,000
9
$27.3M 2.65%
1,226,617
-743,017
10
$24.4M 2.37%
170,891
-164,095
11
$22.8M 2.21%
5,586,169
+1,586,169
12
$21.9M 2.12%
100,406
-9,260
13
$21.2M 2.05%
1,669,777
+798,179
14
$21.2M 2.05%
545,512
+50,000
15
$21M 2.03%
+468,263
16
$20M 1.94%
1,000,869
-516,362
17
$19.7M 1.91%
764,915
-249,201
18
$17.3M 1.68%
576,143
19
$16.8M 1.63%
+867,117
20
$16.7M 1.62%
633,929
-100,000
21
$16.2M 1.57%
+350,000
22
$15.8M 1.53%
1,326,000
+330,000
23
$15.4M 1.49%
291,636
-550,100
24
$15M 1.45%
+350,000
25
$14.6M 1.42%
642,206
-92,204
1
2 3 4